138 related articles for article (PubMed ID: 26008950)
1. Design of novel fluorescent mitochondria-targeted peptides with iron-selective sensing activity.
Abbate V; Reelfs O; Hider RC; Pourzand C
Biochem J; 2015 Aug; 469(3):357-66. PubMed ID: 26008950
[TBL] [Abstract][Full Text] [Related]
2. A Powerful Mitochondria-Targeted Iron Chelator Affords High Photoprotection against Solar Ultraviolet A Radiation.
Reelfs O; Abbate V; Hider RC; Pourzand C
J Invest Dermatol; 2016 Aug; 136(8):1692-1700. PubMed ID: 27109868
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile iron.
Alta RY; Vitorino HA; Goswami D; Liria CW; Wisnovsky SP; Kelley SO; Machini MT; Espósito BP
PLoS One; 2017; 12(2):e0171729. PubMed ID: 28178347
[TBL] [Abstract][Full Text] [Related]
4. Rhodamine labeling of 3-hydroxy-4-pyridinone iron chelators is an important contribution to target Mycobacterium avium infection.
Moniz T; Nunes A; Silva AM; Queirós C; Ivanova G; Gomes MS; Rangel M
J Inorg Biochem; 2013 Apr; 121():156-66. PubMed ID: 23384853
[TBL] [Abstract][Full Text] [Related]
5. The synthesis and properties of mitochondrial targeted iron chelators.
Cilibrizzi A; Pourzand C; Abbate V; Reelfs O; Versari L; Floresta G; Hider R
Biometals; 2023 Apr; 36(2):321-337. PubMed ID: 35366134
[TBL] [Abstract][Full Text] [Related]
6. Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity?
Sturm B; Bistrich U; Schranzhofer M; Sarsero JP; Rauen U; Scheiber-Mojdehkar B; de Groot H; Ioannou P; Petrat F
J Biol Chem; 2005 Feb; 280(8):6701-8. PubMed ID: 15615730
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and properties of novel iron(III)-specific fluorescent probes.
Luo W; Ma YM; Quinn PJ; Hider RC; Liu ZD
J Pharm Pharmacol; 2004 Apr; 56(4):529-36. PubMed ID: 15099448
[TBL] [Abstract][Full Text] [Related]
8. The role of mitochondrial labile iron in Friedreich's ataxia skin fibroblasts sensitivity to ultraviolet A.
Reelfs O; Abbate V; Cilibrizzi A; Pook MA; Hider RC; Pourzand C
Metallomics; 2019 Mar; 11(3):656-665. PubMed ID: 30778428
[TBL] [Abstract][Full Text] [Related]
9. Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications.
Shvartsman M; Kikkeri R; Shanzer A; Cabantchik ZI
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1383-94. PubMed ID: 17670894
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, physicochemical properties, and evaluation of novel iron chelators with fluorescent sensors.
Ma Y; Luo W; Quinn PJ; Liu Z; Hider RC
J Med Chem; 2004 Dec; 47(25):6349-62. PubMed ID: 15566304
[TBL] [Abstract][Full Text] [Related]
11. Development of novel peptides for mitochondrial drug delivery: amino acids featuring delocalized lipophilic cations.
Kelley SO; Stewart KM; Mourtada R
Pharm Res; 2011 Nov; 28(11):2808-19. PubMed ID: 21833796
[TBL] [Abstract][Full Text] [Related]
12. Novel cell-penetrating peptide targeting mitochondria.
Cerrato CP; Pirisinu M; Vlachos EN; Langel Ü
FASEB J; 2015 Nov; 29(11):4589-99. PubMed ID: 26195590
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria Penetrating Peptide-Conjugated TAMRA for Live-Cell Long-Term Tracking.
Zhao T; Liu X; Singh S; Liu X; Zhang Y; Sawada J; Komatsu M; Belfield KD
Bioconjug Chem; 2019 Sep; 30(9):2312-2316. PubMed ID: 31433175
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties.
Nunes A; Podinovskaia M; Leite A; Gameiro P; Zhou T; Ma Y; Kong X; Schaible UE; Hider RC; Rangel M
J Biol Inorg Chem; 2010 Aug; 15(6):861-77. PubMed ID: 20364296
[TBL] [Abstract][Full Text] [Related]
15. Analysis of hydrophobic and hydrophilic moments of short penetrating peptides for enhancing mitochondrial localization: prediction and validation.
Pirisinu M; Blasco P; Tian X; Sen Y; Bode AM; Liu K; Dong Z
FASEB J; 2019 Jul; 33(7):7970-7984. PubMed ID: 30917009
[TBL] [Abstract][Full Text] [Related]
16. Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor.
Petrat F; Weisheit D; Lensen M; de Groot H; Sustmann R; Rauen U
Biochem J; 2002 Feb; 362(Pt 1):137-47. PubMed ID: 11829750
[TBL] [Abstract][Full Text] [Related]
17. Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes.
Ma Y; de Groot H; Liu Z; Hider RC; Petrat F
Biochem J; 2006 Apr; 395(1):49-55. PubMed ID: 16336208
[TBL] [Abstract][Full Text] [Related]
18. A new fluorescent sensor mitoferrofluor indicates the presence of chelatable iron in polarized and depolarized mitochondria.
Kholmukhamedov A; Li L; Lindsey CC; Hu J; Nieminen AL; Takemoto K; Beeson GC; Beneker CM; McInnes C; Beeson CC; Lemasters JJ
J Biol Chem; 2022 Sep; 298(9):102336. PubMed ID: 35931111
[TBL] [Abstract][Full Text] [Related]
19. Accessible Synthetic Probes for Staining Actin inside Platelets and Megakaryocytes by Employing Lifeact Peptide.
Cardo L; Thomas SG; Mazharian A; Pikramenou Z; Rappoport JZ; Hannon MJ; Watson SP
Chembiochem; 2015 Jul; 16(11):1680-8. PubMed ID: 26062886
[TBL] [Abstract][Full Text] [Related]
20. Chelation and mobilization of cellular iron by different classes of chelators.
Zanninelli G; Glickstein H; Breuer W; Milgram P; Brissot P; Hider RC; Konijn AM; Libman J; Shanzer A; Cabantchik ZI
Mol Pharmacol; 1997 May; 51(5):842-52. PubMed ID: 9145923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
